MedPath

CIPRALEX -10MG

CIPRALEX -10MG

Approved
DIN Number

02263238

Drug Class

Human

Market Date

Feb 14, 2005

Company
HC

Lundbeck Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02263238
AIG Number0150435002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AB10 ESCITALOPRAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.04.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

ESCITALOPRAM (ESCITALOPRAM OXALATE)Active
Strength: 10 MG
Monograph: ESCITALOPRAM (ESCITALOPRAM OXALATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.